Squarepoint
FULC icon

Squarepoint’s Fulcrum Therapeutics FULC Stock Holding History

Squarepoint’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$463K Sell
126,558
-49,386
-28% -$300K ﹤0.01% 3486
2026
Q1 		$1.35M Buy
175,944
+110,092
+167% +$1.02M ﹤0.01% 2514
2025
Q4 		$745K Buy
65,852
+48,026
+269% +$489K ﹤0.01% 2863
2025
Q3 		$164K Buy
17,826
+4,151
+30% +$30K ﹤0.01% 4001
2025
Q2 		$94.1K Buy
+13,675
New +$73.1K ﹤0.01% 4179
2024
Q4 		– Sell
-88,130
Closed -$325K – 5174
2024
Q3 		$315K Buy
88,130
+63,613
+259% +$472K ﹤0.01% 3407
2024
Q2 		$152K Sell
24,517
-30,043
-55% -$228K ﹤0.01% 3725
2024
Q1 		$515K Buy
+54,560
New +$487K ﹤0.01% 3029
2023
Q4 		– Sell
-58,900
Closed -$262K – 4166
2023
Q3 		$262K Sell
58,900
-41,891
-42% -$183K ﹤0.01% 3262
2023
Q2 		$333K Sell
100,791
-218,920
-68% -$643K ﹤0.01% 2901
2023
Q1 		$911K Buy
+319,711
New +$2.86M ﹤0.01% 1959
2022
Q3 		– Sell
-30,936
Closed -$152K – 3143
2022
Q2 		$152K Buy
30,936
+567
+2% +$5.54K ﹤0.01% 2545
2022
Q1 		$718K Buy
30,369
+11,140
+58% +$158K ﹤0.01% 1793
2021
Q4 		$340K Buy
+19,229
New +$381K ﹤0.01% 2379
2020
Q2 		– Sell
-13,878
Closed -$166K – 2320
2020
Q1 		$166K Buy
+13,878
New +$222K ﹤0.01% 1536

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint's FULC Position: Q2 2026 in Review

Squarepoint reduced its Fulcrum Therapeutics (FULC) stake by 28% in Q2 2026, selling an estimated $300K and leaving 126,558 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #3486.

Squarepoint first reported a position in FULC in Q1 2020 and has held it in 15 quarters since. The position peaked at $1.35M in Q1 2026. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Squarepoint held 126,558 shares of Fulcrum Therapeutics worth $463K as of Q2 2026.
  • Squarepoint sold 49,386 Fulcrum Therapeutics shares in Q2 2026, an estimated $300K.
  • Fulcrum Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3486 holding.
  • Squarepoint first reported a position in Fulcrum Therapeutics in Q1 2020 and has held it in 15 quarters since.
  • Squarepoint's Fulcrum Therapeutics position peaked at $1.35M in Q1 2026.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.